Gut microbiome-derived metabolites in prostate cancer: microbial mechanisms of immune modulation, androgen metabolism, and therapeutic implications
The global burden of prostate cancer continues to rise, yet conventional biomarkers and therapies face substantial limitations due to tumor heterogeneity and treatment resistance. The gut microbiome has emerged as a critical regulator of host metabolism and immunity, with its bioactive metabolites influencing prostate...